Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PilatesTerapi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.4% 1.6% 1.7% 18.9% 1.9% 1.6% 8.2% 8.2%   Credit score (0-100)   80 77 72 6 69 74 30 30   Credit rating   A A A B A A BB BB   Credit limit (kDKK)   31.6 12.6 3.9 0.0 1.7 20.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,062 2,497 2,159 10,804 223 263 0.0 0.0   EBITDA   1,042 1,008 695 9,308 -43.0 -89.5 0.0 0.0   EBIT   502 820 611 9,265 -43.0 -89.5 0.0 0.0   Pre-tax profit (PTP)   577.0 899.0 655.0 9,434.6 156.0 334.9 0.0 0.0   Net earnings   445.0 698.0 509.0 7,352.6 121.0 260.8 0.0 0.0   Pre-tax profit without non-rec. items   577 899 655 9,435 156 335 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   670 574 244 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   3,511 3,709 3,518 10,871 8,292 8,553 8,053 8,053   Interest-bearing liabilities   2,991 3,057 3,908 31.8 50.0 85.9 0.0 0.0   Balance sheet total (assets)   7,071 7,267 7,990 11,023 8,415 8,771 8,053 8,053   Net Debt   2,328 2,315 2,325 -178 -180 -57.3 -8,053 -8,053     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,062 2,497 2,159 10,804 223 263 0.0 0.0   Gross profit growth   -2.5% -18.5% -13.5% 400.4% -97.9% 18.1% -100.0% 0.0%   Employees   5 4 3 2 1 1 0 0   Employee growth %   25.0% -20.0% -25.0% -33.3% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,071 7,267 7,990 11,023 8,415 8,771 8,053 8,053   Balance sheet change%   8.0% 2.8% 9.9% 38.0% -23.7% 4.2% -8.2% 0.0%   Added value   1,042.0 1,008.0 695.0 9,308.2 0.3 -89.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -986 -284 -414 -287 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   16.4% 32.8% 28.3% 85.8% -19.3% -34.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   10.4% 14.2% 10.1% 99.5% 1.6% 3.9% 0.0% 0.0%   ROI %   11.4% 15.2% 10.8% 103.0% 1.6% 4.0% 0.0% 0.0%   ROE %   11.7% 19.3% 14.1% 102.2% 1.3% 3.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   49.7% 51.0% 44.0% 98.6% 98.5% 97.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   223.4% 229.7% 334.5% -1.9% 418.6% 64.0% 0.0% 0.0%   Gearing %   85.2% 82.4% 111.1% 0.3% 0.6% 1.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.6% 3.9% 3.2% 1.1% 2.4% 3.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   11.1 13.9 12.8 73.3 52.0 31.0 0.0 0.0   Current Ratio   11.1 13.9 12.8 73.3 52.0 31.0 0.0 0.0   Cash and cash equivalent   663.0 742.0 1,583.0 209.5 230.0 143.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   5,351.0 5,984.0 6,914.0 10,872.7 6,271.0 6,530.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   208 252 232 4,654 0 -90 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   208 252 232 4,654 -43 -90 0 0   EBIT / employee   100 205 204 4,632 -43 -90 0 0   Net earnings / employee   89 175 170 3,676 121 261 0 0